Glaxo Faces $489M in Allegations of Economic Crimes

July 16 (Bloomberg) -- China is investigating at least four multinational drugmakers as it widens its probe of GlaxoSmithKline, according to a lawyer in Hong Kong whose firm advises companies on cross-border anti-corruption. Ryan Chilcote reports on Bloomberg Television's "Countdown." (Source: Bloomberg)

Opportunities and Challenges in China's Fintech Industry
32:57 - Sebastiaan van den Berg, chief investment officer and head of principal investments at Sun Hung Kai & Co., discusses the opportunities and challenges in China's fintech industry. He speaks on "Bloomberg Markets: Asia." (Source: Bloomberg)
  • China's Big Plans for the Robot Industry
  • Chinese Regulators Eye Entrusted Investments
  • Amundi's Ameli-Renani Sees Value in Mexico